NCT04258969

Pedaling at a Low-Moderate Intensity During Chemotherapy Administration

Evaluating the Feasibility of Pedaling at a Low-moderate Intensity During Chemotherapy Infusions in Colorectal Cancer Patients.

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Rush University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the feasibility of completing a low-moderate intensity pedaling session concurrent to chemotherapy treatment for colorectal cancer. Secondary objectives for this study consist of evaluating the role of pedaling on sarcopenia rates, quality of life markers, chemotherapy side effects, rate of hospital admissions, and treatment delays.

Conditions

• Colorectal Cancer
• Exercise, Aerobic
• Chemotherapy
• Chemotherapeutic Toxicity

Interventions

Type	Name	Description
BEHAVIORAL	Pedaling	Participants will pedaling at a low-moderate intensity using a stationary pedal ergometer concurrent to their chemotherapy (FOLFOX or FOLFIRI) infusion. Participants will cycle for 30 min within the first 2 hours of their infusion.

Timeline

• Start date: 2020-01-11
• Primary completion: 2021-10-14
• Completion: 2021-10-14
• First posted: 2020-02-06
• Last updated: 2024-10-01

Locations

1 site across 1 country: United States